You are here

XG Sciences secures financing from The Dow Chemical Company

Jan 05, 2017

XG Sciences logoXG Sciences, a supplier of graphene nanoplatelets and value-added products containing graphene nanoplatelets, recently announced that it has closed an agreement with The Dow Chemical Company for up to a $10 million senior credit facility, which may be drawn down in tranches by XGS at its discretion through December 2019.

The company received $2 million under this facility at close and may draw another $3 million at its discretion at any time prior to the first anniversary of the agreement. After the first anniversary of the closing, the company may access the remaining $5 million, provided it has raised at least $10 million of additional equity capital. XG Sciences and Dow agreed to hold commercial discussions including the potential out-license of certain of Dow’s manufacturing IP related to graphene nanoplatelets to XGS.

Versarien enters agreement with Fern Plastic Products to manufacture graphene-enhanced injection moulded products

Dec 20, 2016

Versarien announced an agreement with Fern Plastic Products to manufacture injection moulded products using graphene-enhanced polyaryletherketone (PAEK) materials. The agreement with Fern Plastics follows the agreement with Scafell Organics announced earlier this month.

The plan is for Versarien to utilize Fern Plastics' manufacturing facilities and expertise to produce injection moulded products using graphene-enhanced PAEK materials produced through Versarien's collaboration with Scafell.

Versarien enters agreement with Scalfell Organics to develop graphene-enhanced PAEK materials

Dec 18, 2016

Versarien logo imageVersarien, the advanced materials group, has signed an agreement with polymer chemical producer Scafell Organics to develop graphene-enhanced polyaryletherketone materials (PAEKs). These materials are a family of semi-crystalline thermoplastics with high-temperature stability and high mechanical strength, used in the automotive and aerospace industries.

Versarien reportedly plans to utilize Scafell’s facilities and production expertise to produce graphene enhanced PAEK materials using Versarien supplied graphene nano platelets. It is hoped that these graphene enhanced materials will be available for sale by Versarien through its sales team as well as Scafell’s customers.

Versarien secures a significant graphene order

Nov 30, 2016

Versarien logo imageVersarien, the advanced materials group, announced the receipt of a significant graphene order for a carbon fibre composite related OEM application.

Versarien has received an order with a value of over £100,000 (around $124,900 USD) for graphene in the form of Few Layer Graphene Nano Platelets (GNPs) from a European commercial customer, in conjunction with the NGI. This graphene will be certified by the NGI and Versarien will be handling the dispersion of the GNPs into the resin to be used by the customer. The resin will be provided by the customer free of charge and will be returned to the customer in Europe once mixed with Versarien's GNPs.

Directa Plus reports €440,000 in revenues for 1H2016, to co-develop graphene-enhanced spectacles

Nov 16, 2016

Directa Plus logoItaly-based Directa Plus announced its financial results for the first half of 2016. Revenues reached €440,000 (up from €270,000 in 1H2016) and a net loss of €2.3 million (up from €1.3 million in 1H 2015). The company had €13.1 million in cash and equivalents as of the end of July 2016.

Directa Plus also reported some interesting new business activities and milestones. The company now has over 10 active customers (up from only three in July 2015), and it delivered 1.8 tonnes of graphene materials. Directa Plus also signed a two-year joint development agreement with a global luxury accessories producer in order to develop an entire generation of graphene-enhanced spectacles.